Gov. JB Pritzker named Doug Peterson, the director of AI strategy and implementation for Chicago-based pharmaceutical company ...

Following the release of upbeat data and given some recent signs of stabilization in the stocks, MarketWatch took at look at companies in the healthcare sector that are expected to produce the fastest ...

AbbVie (ABBV) continued gains for seven straight sessions of gains, as the stock closed higher Friday. The North ...

The Mayo Super League title race is heating up after a dramatic round of midweek fixtures saw twists at the top of the table.

Novo Nordisk announces that CVS Caremark®, the country's largest PBM, has decided Wegovy® will be the preferred GLP-1 ...

Xiangxiang Ma, a partner of Anjie Broad Law Firm, explores the various ways in which a recent U.S. executive order on drug pricing is impacting Chinese pharmaceutical companies’ license-out model ...

The Dividend Aristocrats are a group of 69 stocks in the S&P 500 Index with over 25 consecutive years of dividend increases. These high-quality businesses have managed recessions and various crises, ...

AbbVie inched up 0.17% to $187.66, bucking the broader market’s downward trend. While the S&P 500 dipped 0.53%, AbbVie ...

The latest trading day saw AbbVie (ABBV) settling at $187.66, representing a +0.17% change from its previous close.

Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed ...

ROCKVILLE, MD, USA I June 5, 2025 I REGENXBIO Inc. (Nasdaq: RGNX) today announced new positive interim data from the Phase ...

Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...